KAREN DOHL: Open Payments
NPI 1144298068 · LEWISBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$849 in 40 payments from 14 companies in 2025. Trend: 2023 $197 · 2024 $604 · 2025 $849
Food & beverage: $849
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $154 |
| Novo Nordisk Inc | 8 | $147 |
| Lilly USA, LLC | 7 | $147 |
| Exact Sciences Corporation | 4 | $100 |
| ABBVIE INC. | 5 | $86 |
| Dexcom, Inc. | 3 | $52 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $28 |
| PFIZER INC. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
Products named: BREZTRI, Cologuard Collection Kit, JARDIANCE, Wegovy, MOUNJARO, VRAYLAR, Dexcom G6 Transmitter, Ozempic.
Industry payments across PA — which companies pay providers there.
